News

Reference Apotex Corp. issues voluntary nationwide recall of Enoxaparin Sodium Injection, USP due to mislabeling of syringe barrel measurement markings. [press release].
Syringe marking errors, which can lead to incorrect dosing, caused a recall of Enoxaparin Sodium Injection, a generic version of blood clot medication Lovenox.
Each syringe contained 2.5 mg of fondaparinux sodium in 0.25 ml of water for injectable preparations (a concentration of 10 mg per milliliter), 30 mg of enoxaparin sodium in 0.3 ml of water for ...
Techdow USA is introducing 30 mg, 40 mg, 60 mg, 80 mg, 100 mg, 120 mg and 150 mg strengths of generic Enoxaparin Sodium (Preservative Free) Prefilled Syringes, which is the generic of Sanofi ...
Enoxaparin Medication Information Learn everything you need to know about Enoxaparin-pronunciation, uses, dosage guidelines, indications, and when to take or avoid it.
Apotex recalled two batches of the anticoagulant enoxaparin after its contract manufacturer discovered it had packaged the drug in syringes with incorrect measurement markings.
Unilife has agreed to supply Sanofi with the Unifill Finesse™, a customized device from its Unifill® platform of prefilled syringes with automatic, needle retraction, for use with the anti-thrombotic ...
The French company agreed to buy 150 million syringes a year, and Unilife expects to get between $5 million and $15 million in milestone payments out of the deal, which can be extended through 2024.
Syringe marking errors, which can lead to incorrect dosing, caused a recall of Enoxaparin Sodium Injection, a generic version of blood clot medication Lovenox.
Syringe marking errors, which can lead to incorrect dosing, caused a recall of Enoxaparin Sodium Injection, a generic version of blood clot medication Lovenox.
Syringe marking errors, which can lead to incorrect dosing, caused a recall of Enoxaparin Sodium Injection, a generic version of blood clot medication Lovenox.